PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
AMG 172 First in Human Study in Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Rollover Protocol for Subjects Previously Treated With AGS-003
- Status
- TERMINATED
- Phase
- PHASE2
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
- Status
- TERMINATED
- Phase
- N/A
Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
- Status
- TERMINATED
- Phase
- PHASE2
Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Association Between Hepatitis C Infection and Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- NA
Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
HYPAZ: Hypertension Induced by Pazopanib
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of MGA271 in Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Pazopanib in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Biomarker Study (BMS-936558)
- Status
- COMPLETED
- Phase
- PHASE1
BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.
- Status
- COMPLETED
- Phase
- N/A
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1